Nigeria: Biovaccines Pledges to Produce Covid-19 Vaccines in Nigeria


Nigeria’s local vaccine production company, Biovaccines Nigeria Limited (BVNL) has said it will ensure that Nigeria is served coronavirus vaccines simultaneously with other parts of the world as soon as the World Health Organisation (WHO) gives its nod for the use of any of the several COVID-19 vaccine candidate.

This it stated it would achieve through a partnership with international technical partners which are currently working on WHO approval of COVID-19 vaccines. The technical partners will bulk produce for BVNL.

To ensure that this happens Biovaciines is acquiring modular fill and finishing lines for the finishing of the vaccines in Nigeria by way of filling and capping. In readiness for this role Biovaccines earlier this month signed a Memorandum of Understanding (MOU) for Market Access with the Federal Ministry of Health which enables her to serve approved vaccines of her international technical partners to the Nigerian market.

Speaking at the MOU signing ceremony, BVNL Board Chairman, Prof. Adewole Tomori, said the company was satisfied with the cooperation and support it was receiving from the administration of President Muhammad Buhari and assured that the local manufacturing of vaccines in Nigeria will materialize in no distant time. He enumerated the benefits of the BVNL project to include job creation, foreign exchange earnings from export, development of biotechnological base, ability to develop novel vaccines for fighting Africa-specific diseases, security of quality vaccines, dealing efficiently with pandemic diseases and outbreaks, socio-economic development and enduring partnership opportunities.